The upregulation of disulfidptosis related genes SLC3A2 and SLC7A11 promotes the occurrence and progression of glioma tumors, therefore, a signal target of disulfidptosis may be used in the therapeutic schedule for neurogliomas. The gene discussed is SLC3A2; the disease is central nervous system cancer.